GT Medical Technologies announced today that it completed a $37 million first close of a Series D financing round.

For instance, in October 2021, the US Food and Drug Administration (FDA) granted breakthrough device designation to Alpha Tau's alpha-radiation cancer therapy to treat patients suffering from ...

GT Medical Technologies, Inc. (GT MedTech), a medical device company with a corporate purpose of improving the lives of ...

The global dosimetry market is projected to grow from USD 3,144.10 million in 2024 to USD 4,882.60 million by 2034, at a CAGR ...

The global medical physics market is forecasted to grow from USD 5.3 billion in 2024 to USD 10 billion by 2034, at a CAGR of ...

The court concluded genuine issues of material fact existed regarding whether an advanced warning of the alleged risks of a ...

AIG Hospitals to acquire state-of-the-art Proton Beam Therapy system for advanced cancer treatment in South-East Asia.

Dublin, Jan. 07, 2025 (GLOBE NEWSWIRE) -- The "Radiotherapy/Radiation Oncology Devices - Market Insights, Competitive Landscape, and Market Forecast -2030" report has been added to ...

The US Food and Drug Administration (FDA) has granted breakthrough device designation to PreludeDx's DCISionRT test, a risk ...